Head of Section: Jonas R. Henriksen
Section for Biotherapeutic Engineering and Drug Targeting consists of research groups dedicated to development of advanced materials, drug delivery systems, and cell-based therapies for treatment of a range of different diseases. Activities include the development of (i) radionuclides for real-time bioimaging, (ii) nanotechnological solutions to improve the efficacy of immunotherapy in different cancer conditions, (iii) novel drugs and drug delivery strategies capable of traversing impenetrable biological membranes, (iv) biosensors to characterized cellular responses, (v) multifunctional biomaterials facilitating simultaneous drug release and tissue scaffolding with the possibility of detection using various bioimaging modalities.
Bioimaging is a core resource for many researchers in the section, including light and electron microscopy, computed tomography (CT), positron emission tomography (PET), single photon emission computed tomography (SPECT), and fluorescence in vivo imaging systems (IVIS). The section is multidisciplinary and employs researchers with greatly varying background spanning from chemistry and biophysics to veterinary science and medicine.